AKT1 and lung cancer: Functionally, the knockdown of KIF18B reduced proliferation, migration, and invasion of A549 cells, which was associated with reductions in the expression of Rac1-GTP, phospho-AKT, and phospho-mTOR [151], suggesting it may also be therapeutically relevant in lung cancer.